List of Programs

Global Health

In today’s global economy, diseases have the potential to spread at warp speed. To protect the health of Americans and to address worldwide health threats, CDC is actively engaged in sharing knowledge and expertise in public health with international partners. The CDC Foundation helps CDC fight global health threats by fostering collaborations between CDC and other groups to support a variety of international health programs.

Global Health Programs

Addressing Health Disparities in the US and Brazil

To examine racial disparities in health and develop a joint action plan between the United States and Brazil. The partnership will facilitate cross-country collaboration by examining, disseminating  and applying innovative approaches to reducing or eliminating racial discrimination in health for black populations.

  • Funding Partners: W.K. Kellogg Foundation
  • Program Partners: CDC’s Office of Minority Health and Health Equity; Brazil Ministry of Health

> Addressing Health Disparities in the US and Brazil

Aetiology of Neonatal Infection in South Asia

To characterize the pathogens that cause infections in young infants in developing countries - particularly Bangladesh, Pakistan and India - including a description of incidence, antimicrobial susceptibility and strain properties.

  • Funding Partners: Child Health Research Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Aetiology of Neonatal Infection in South Asia

Atlanta International Health Fellowship Endowment

To provide funds for international participants to come to Atlanta to take part in public health courses at CDC or Emory University.

  • Funding Partners: The Tull Charitable Foundation, multiple individuals and organizations
  • Program Partners: Epidemic Intelligence Service, Emory University, Villa International

> Atlanta International Health Fellowship Endowment

Bed Nets for Children

To help CDC teams in Africa and Haiti purchase and distribute insecticide-treated bed nets to protect children and pregnant women from malaria.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Bed Nets for Children

Bloomberg Initiative to Reduce Tobacco Use

To create the Global Adult Tobacco Survey (GATS), a standard global surveillance system to monitor adult tobacco use and critical tobacco control measures, to inform, track and implement national and global programs and policies to reduce tobacco use.

  • Funding Partners: Bloomberg Philanthropies; Bill and Melinda Gates Foundation
  • Program Partners: CDC, World Health Organization

> Bloomberg Initiative to Reduce Tobacco Use

Bob Keegan Polio Eradication Heroes Fund

The Bob Keegan Polio Eradication Heroes Fund recognizes health workers and volunteers who have incurred serious injury or lost their lives as a direct consequence of their participation in polio eradication activities. The families of the workers, who have been the victims of automobile crashes, military conflicts and other life-threatening events, receive a certificate recognizing the victim’s heroic commitment to polio eradication and a cash tribute.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Bob Keegan Polio Eradication Heroes Fund

CDC-Hubert Global Health Fellowship

To provide an opportunity for third- and fourth-year medical and veterinary students to gain public health experience in an international setting. Hubert fellows spend six to twelve weeks in a developing country working on a priority health problem in conjunction with CDC staff.

  • Funding Partners: O.C. Hubert Charitable Trust
  • Program Partners: CDC's Office of Surveillance, Epidemiology and Laboratory Services

> CDC-Hubert Global Health Fellowship

Central Asia Blood System Evaluation

To evaluate the blood donor recruitment system, the quality of laboratory screening procedures for blood donations, and the current guidelines for the clinical use of blood components in four countries in central Asia. To identify gaps in blood services, make recommendations to address those gaps, and then implement and evaluate proposed interventions in the problem areas.

  • Funding Partners: International Bank for Reconstruction and Development
  • Program Partners: Central Asia AIDS Project, The World Bank Group, CDC's Center for Global Health

> Central Asia Blood System Evaluation

Cervical Cancer Screening and Treatment

To scale and improve cervical cancer screening and treatment programs globally through a consortium-based approach – Improving Data for Global Cervical Cancer Screening and Treatment Programs.

  • Funding Partners: Bill and Melinda Gates Foundation
  • Program Partners: CDC’s Center for Global Health

> Cervical Cancer Screening and Treatment

Chronic Kidney Disease in Central American Workers

To investigate potential occupational causes of Chronic Kidney Disease in Central American countries.

  • Funding Partners: Los Azucareros del Istmo Centroamericano
  • Program Partners: CDC's Center for Global Health; CDC’s National Center for Environmental Health; Boston University School of Public Health

> Chronic Kidney Disease in Central American Workers

Compassion Fund for CDC's Global Health Workers

CDC employs more than 1,300 staff in 40+ countries around the world. This fund provides financial relief to the families of staff killed or disabled while doing their job.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Compassion Fund for CDC's Global Health Workers

Diagnosis of Pneumonia and Sepsis in Thailand

To evaluate the use of real-time polymerase chain reaction and the Binax NOW® S.pneumoniae immuno-chromatographic test for diagnosis of pneumococcal pneumonia and sepsis in Thailand.

  • Funding Partners: Johns Hopkins Bloomberg School of Public Health
  • Program Partners: CDC's Center for Global Health

> Diagnosis of Pneumonia and Sepsis in Thailand

Differing Antibody Responses to Multiple Polio Strains

To examine the population immune response to both the immunizing antigen and the wild polio virus in an endemic country in order to analyze differences in vaccine response among different geographical regions.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's Center for Global Health

> Differing Antibody Responses to Multiple Polio Strains

Dissemination and Use of Health Surveillance Data

  • Funding Partners:
  • Program Partners:

> Dissemination and Use of Health Surveillance Data

Drug-resistant Candida - South Africa

To describe species distribution of Candida spp. causing bloodstream infection and its resistance to at least four antifungal drugs (fluconazole, voriconazole, amphotericin B, caspofungin) and to compare the results with previous studies and between public and private health sectors in South Africa.

  • Funding Partners: Merck Sharp & Dohme Corp.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infections

> Drug-resistant Candida - South Africa

Emergency Obstetric Care in Tanzania

To improve access to quality emergency obstetric care and reduce maternal deaths in four pilot regions of Tanzania.

  • Funding Partners: Bloomberg Philanthropies
  • Program Partners: CDC - Tanzania

> Emergency Obstetric Care in Tanzania

Emerging Infectious Diseases in China

To enable a Pfizer Global Health Fellow to work alongside CDC scientists on assignment in China to improve prevention, detection and control of emerging infectious diseases.

  • Funding Partners: Pfizer Inc
  • Program Partners: CDC's Center for Global Health

> Emerging Infectious Diseases in China

Endowment for Global Health Priorities

To provide a source of flexible funding to CDC teams working in the field to meet critical or emergency needs that could not easily be met through usual government channels. Since it was created in 1999 by a group of CDC employees and retirees, the fund has provided resources for essential services and equipment such as bullet-proof vests for health workers vaccinating children in war-torn Somalia, meals-ready-to-eat for workers in Sudan, satellite phones, incentives for vaccination campaigns in Mexico and India and training in other countries.

  • Funding Partners: Google, Inc.; multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Endowment for Global Health Priorities

Evaluating Safe Water Interventions

To support CDC's work with international partners to develop and evaluate new tools and strategies to improve access to safe drinking water at a household level.

  • Funding Partners: The Clorox Company; Procter & Gamble Company; Vestergaard Frandsen SA; The Greater Cincinnati Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Evaluating Safe Water Interventions

Evaluation of Malaria Specimen Bank

To analyze blood samples to determine what species of human malaria parasites are present in the specimens as part of an evaluation of a global malaria specimen bank.

  • Funding Partners: Foundation for Innovative New Diagnostics
  • Program Partners: CDC's Center for Global Health

> Evaluation of Malaria Specimen Bank

Evaluation of “Water for Health” in Uganda

To evaluate the impact of “Water for Health,” a program aimed at increasing use of perinatal services and improving household water treatment and hygiene practices in Uganda. The program provides free hygiene kits and education to pregnant women as incentives to motivate attendance at antenatal clinics and delivery in 45 health facilities among six districts.

  • Funding Partners: Procter & Gamble (P&G)
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)

> Evaluation of “Water for Health” in Uganda

Family Planning Project in Tanzania

To expand on an existing program to increase access to comprehensive emergency obstetric care (CEmOC) in Tanzania by integrating family planning (FP), comprehensive post-abortion care (CPAC) and family planning advocacy in ten health centers and add new health centers in Kigoma to be upgraded for the full package of CEmOC, FP and CPAC.

  • Funding Partners: Bloomberg Philanthropies
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health

> Family Planning Project in Tanzania

Field Epidemiology Training Program - Saudi Arabia

To evaluate Saudi Arabia's infectious disease surveillance system, help train local and regional disease detectives and improve the country's capacity to monitor for and respond to infectious disease outbreaks.

  • Funding Partners: Kingdom of Saudi Arabia Ministry of Health
  • Program Partners: CDC's Center for Global Health

> Field Epidemiology Training Program - Saudi Arabia

Food Fortification Initiative

To promote the use of foods fortified with iron, zinc, calcium and folate around the world by encouraging the production and marketing of fortified flour and other products.

  • Funding Partners: AkzoNobel N.V.; Bresky Foundation; Bühler Group; Cargill; Global Alliance for Improved Nutrition (GAIN); Hexagon Nutrition Pvt. Ltd.; Höganäs AB; International Association of Operative Millers; Industrial Metal Powders; Micronutrient Initiative; Navkar bio-chem; PD Brothers; UNICEF
  • Program Partners: Australian Wheat Board; Emory University; Fleishman-Hillard, Inc.; General Mills, Inc.; InterFlour; Modern Flour Mills and Macaroni Factories, Co.; World Health Organization; CDC's National Center for Chronic Disease Prevention and Health Promotion

> Food Fortification Initiative

Gangarosa Endowment for Safe Water

Reflecting a lifelong commitment to provide safe water around the world, Dr. Eugene Gangarosa and his wife, Rose, established the Gangarosa Endowment for Safe Water in May 2000 to provide an ongoing source of support for CDC's safe water initiatives.

  • Funding Partners: Gangarosa International Health Foundation, Inc.; multiple individuals and organizations
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Gangarosa Endowment for Safe Water

Global Adult Tobacco Survey

To create, as a component of the Bloomberg Initiative to Reduce Tobacco Use, a standard global surveillance system to monitor adult tobacco use and critical tobacco control measures to inform, track and implement national and global programs and policies to reduce tobacco use.

  • Funding Partners: Bloomberg Philanthropies; Bill & Melinda Gates Foundation
  • Program Partners: World Health Organization; Johns Hopkins Bloomberg School of Public Health; RTI International; CDC's National Center for Chronic Disease Prevention and Health Promotion

> Global Adult Tobacco Survey

Global Hepatitis Program Fellow

To expand CDC's capacity to support the development of a WHO Global Hepatitis Program by providing a fellow who will, under guidance from the CDC Medical Officer assigned to WHO,  develop viral hepatitis screening and treatment guidelines and provide expertise on chronic viral hepatitis control at WHO, serve as a resource for viral hepatitis prevention and vaccination activities to WHO regional offices, provide technical support for WHO’s global burden of hepatitis disease project, and develop and support WHO’s Plan of Action for World Hepatitis Day.

  • Funding Partners: Merck & Co., Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Global Hepatitis Program Fellow

Global Rotavirus Reference Laboratory

To help CDC serve as a Global Reference Laboratory for the rotavirus laboratory network, which provides support to the global rotavirus surveillance network coordinated by the World Health Organization.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Global Rotavirus Reference Laboratory

Global VPIBD Reference Laboratory

To help CDC serve as a Global Reference Laboratory for the vaccine-preventable invasive bacterial diseases (VPIBD) laboratory network, which provides support to the global VPIBD surveillance network coordinated by the World Health Organization.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's Center for Global Health

> Global VPIBD Reference Laboratory

HPV Vaccine Evaluation in Kenya

To help CDC conduct assessments in Kenya to evaluate knowledge, beliefs and acceptability of the HPV vaccine.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> HPV Vaccine Evaluation in Kenya

Improving Health Care Provider Performance in Developing Countries

To generate evidence-based recommendations via a systematic literature review on how to improve health care providers' performance in low-and middle-income countries.

  • Funding Partners: The Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Improving Health Care Provider Performance in Developing Countries

Improving Public Health Management for Action

To improve health outcomes in low-resource countries, in the areas of polio and other vaccine-preventable diseases, enteric diseases, maternal and child health, through the development of a training program for mid-level public health managers in partnership with scientists and technical experts.

  • Funding Partners: Bill and Melinda Gates Foundation
  • Program Partners: CDC’s Center for Global Health

> Improving Public Health Management for Action

Influenza Vaccine Donation to Low-Income Countries

To ensure that high-risk populations in low-income countries have access to life-saving influenza vaccines. The project will match donated vaccine and supplies from private companies and technical support from CDC and WHO with countries that are committed to introducing or expanding their influenza vaccine programs. The program will build on a pilot project in Laos to serve as a catalyst for sustainable influenza vaccine programs in other partner countries.

  • Funding Partners: (from in-kind donations) bioCSL, BD (Becton, Dickinson and Company)
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases, Lao People's Democratic Republic, Republic of Nicaragua, World Health Organization, U.S. Department of Defense, Walgreens, UPS

> Influenza Vaccine Donation to Low-Income Countries

Intervention Study in Guatemala

To design and execute an intervention study to address severe morbidity due to diarrhea and intestinal parasites in children under five in Guatemala.

  • Funding Partners: Global Health Partnership Initiative
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Intervention Study in Guatemala

Investigating Chronic Kidney Disease in Nicaragua

To facilitate collaboration and investigate the potential of non-occupational causes of chronic kidney disease in Nicaragua in connection with the Chronic Kidney Disease Research initiative in Central America.

  • Funding Partners: Comité Nacional de Productores de Azúcar
  • Program Partners: CDC’s Center for Global Health; CDC’s National Center for Environmental Health; Boston University School of Public Health

> Investigating Chronic Kidney Disease in Nicaragua

KSHV in Sub-Saharan Africa

To test blood and saliva samples from Uganda, Zimbabwe and South Africa for Kaposi sarcoma-associated herpesvirus (KSHV) antibodies and DNA; to measure KSHV seroprevalence and seroincidence; to analyze determinants of KSHV infection; and to examine the response of KSHV infection to antiretroviral therapy.

  • Funding Partners: University of California, San Francisco
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> KSHV in Sub-Saharan Africa

Labs for Life Fellowship

To support CDC’s Center for Global Health on a five-year public-private partnership between BD and PEPFAR focused on improving overall laboratory systems and services in Uganda, Ethiopia, Kenya, Mozambique and India, countries severely affected by HIV/AIDS and tuberculosis.

  • Funding Partners: BD (Becton, Dickinson and Company)
  • Program Partners: CDC's Center for Global Health, U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)

> Labs for Life Fellowship

Leveraging Rotavirus Networks

To determine the performance characteristics of tacrolimus-based (TAC) genotyping in comparison to conventional genotyping assays to better assess the role of different enteric pathogens in diarrhea requiring hospitalization among children less than five years of age. The technology will advance the analysis of rotavirus vaccine effectiveness studies by revealing how often cases of rotavirus vaccine failure are actually infections due to other enteric pathogens.

  • Funding Partners: Bill and Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases, World Health Organization, University of Virginia

> Leveraging Rotavirus Networks

Louise Martin, D.V.M., M.S. EIS '85 Endowed Memorial Scholarship

When a terrorist bomb exploded at the American Embassy in Nairobi, Kenya on August 7, 1998, Mary Louise Martin was among the 12 Americans and more than 200 Kenyans killed. In her memory, friends and colleagues established the Louise Martin, D.V.M., M.S., EIS '85 Memorial Scholarship Endowment to provide scholarships for disadvantaged young women in Kenya to attend a national school.

  • Funding Partners: Battelle; Walter R. Dowdle, Ph.D., EIS Hon. '91; Taskforce for Global Health; multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Louise Martin, D.V.M., M.S. EIS '85 Endowed Memorial Scholarship

Lymphatic Filariasis Morbidity Control in Mali

To improve the quality of life for those experiencing chronic complications of lymphatic filariasis in sub-Saharan Africa by providing access to a lymphedema management program in Mali.

  • Funding Partners: The Izumi Foundation
  • Program Partners: Mali Ministry of Health; CDC's Center for Global Health

> Lymphatic Filariasis Morbidity Control in Mali

Malaria Host-Pathogen Interaction Center (MaHPIC)

To study and catalog in molecular detail how malaria parasites interact with their human and other animal hosts and cause disease using the “systems biology” approach. The project will integrate data generated by malaria research, functional genomics, proteomics, lipidomics and metabolomics cores, with the aid of informatics and computational modeling cores. CDC will be providing project support by generating proteomic data in the context of the project’s Proteomics Core and the Malaria Core.

  • Funding Partners: National Institutes of Health
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases and Center for Global Health, Emory University, University of Georgia, Georgia Institute of Technology

> Malaria Host-Pathogen Interaction Center (MaHPIC)

Malaria in Pregnancy

To evaluate the impact of malaria on pregnancy outcomes in Latin American countries.

  • Funding Partners: Liverpool School of Tropical Medicine
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Malaria in Pregnancy

MenAfriNet Meningitis Surveillance in Africa

To establish a regional surveillance network – MenAfriNet – to collect and analyze high quality case-based meningitis surveillance data from representative sites across the African meningitis belt. The meningitis surveillance network will evaluate the impact of MenAfriVac to guide research on new vaccines and strategies to optimize impact of existing vaccines.

  • Funding Partners: Bill and Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases, WHO-AFRO, Agence de Medicine Preventive, Ministries of Health and other non-governmental agencies

> MenAfriNet Meningitis Surveillance in Africa

mHealth: Text Messaging Campaign in Tanzania

To provide informative test messages and appointment reminders in Swahili at no charge to pregnant women and mothers of newborn babies, as well as to supporters. The text messaging campaign, “Wazazi Nipendeni,” is led by the mHealth Tanzania Public Private Partnership. Through the campaign, the government of Tanzania is working to reduce the number of newborn and maternal deaths by three-quarters by 2015.

  • Funding Partners: CDC, USAID, PEPFAR
  • Program Partners: CDC, CDC Foundation, Ministry of Health and Social Welfare and many others

> mHealth: Text Messaging Campaign in Tanzania

Mobilizing CDC's Global Health Force

To provide funding and facilitate the purchase of vehicles to transport critical public health supplies, personnel and equipment to regions where they are needed most.

  • Funding Partners: General Motors Foundation
  • Program Partners: CDC's Center for Global Health

> Mobilizing CDC's Global Health Force

PEPFAR Public-Private Partnerships

To leverage partnerships to fight HIV/AIDS, TB, malaria and other diseases in 10 developing countries supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Efforts include mHealth activities in Kenya and Tanzania and the establishment of a training program in laboratory equipment maintenance and repair in Nigeria.

  • Funding Partners: The Bill & Melinda Gates Foundation; Motorola Foundation
  • Program Partners: PEPFAR; CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> PEPFAR Public-Private Partnerships

Philippine Blood Bank System Evaluation

To support the Republic of the Philippines in the prevention of HIV and other pathogen transmission during blood transfusion by providing an assessment of blood bank system safety and quality control parameters. Blood transfusion using donor-provided blood for medical purposes carries the risk of transmitting HIV, Hepatitis B, Hepatitis C and other pathogens.

  • Funding Partners: Republic of the Philippines Department of Health
  • Program Partners: CDC’s Center for Global Health, Division of Global HIV/AIDS, Thailand Asia Regional Office and the University of the Philippines Manila’s Institute of Clinical Epidemiology

> Philippine Blood Bank System Evaluation

Pneumococcal Vaccine Effectiveness in HIV-Infected Children

To estimate the effectiveness of two or more doses of 13-valent pneumococcal conjugate vaccine (PCV-13) against laboratory-confirmed vaccine-serotype invasive pneumococcal disease (IPD) (13 serotypes in the vaccine) among HIV-infected and HIV-uninfected children eligible to receive vaccination through the routine vaccination program in South Africa, compared to no vaccination.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Pneumococcal Vaccine Effectiveness in HIV-Infected Children

Pneumococcal Vaccine Impact in Kenya

To examine vaccine impact in Kenya before and after the pneumococcal vaccine, PCV10, was introduced. This is a five-year study in collaboration with Kenya Medical Research Institute.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases, Kenya Medical Research Institute (KEMRI)

> Pneumococcal Vaccine Impact in Kenya

Pneumonia Etiology Research for Child Health

To establish a case control study of severe acute lower respiratory infections in children under age 5 in Thailand to determine the etiology and risk factors associated with pneumonia.

  • Funding Partners: Johns Hopkins Bloomberg School of Public Health
  • Program Partners: CDC - Thailand

> Pneumonia Etiology Research for Child Health

Polio Vaccine Response in Children in MAL-ED Study

To characterize the effect of malnutrition, diarrheal disease, diet, concurrent infections, gut functions and vaccination schedule in response to poliovirus vaccination. The Polio and Picornavirus Laboratory Branch in the Division of Viral Diseases at CDC’s National Center for Immunization and Respiratory Diseases will test serum samples from enrollees in the Mal-ED (Interactions of Malnutrition & Enteric Infections: Consequences for Child Health Development) cohort study for neutralizing antibodies to poliovirus 1, 2 and 3.

  • Funding Partners: Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Polio Vaccine Response in Children in MAL-ED Study

Primate Retroviral Transmission

To track the transmission of blood-borne microbes between non-human primates and domestic animals living near Kibale National Park, Uganda.

  • Funding Partners: University of Wisconsin
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Primate Retroviral Transmission

Promoting Global Non-communicable Disease Prevention

To build applied research capacity for addressing non-communicable disease prevention in low- and middle-income countries by developing a curriculum, leading seminars and workshops in target countries and regions, collaborating with environmental and sustainability programs active in target countries and mentoring Emory University public health students from target countries.

  • Funding Partners: The Coca-Cola Company
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Promoting Global Non-communicable Disease Prevention

Rabies Prevention in Developing Countries

To support CDC's work with partners in the Philippines and Central Africa to prevent and reduce rabies transmission between animals and humans through increased vaccination and education.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infections

> Rabies Prevention in Developing Countries

Reducing HIV Acquisition through PrEP - Uganda

To assess, through clinical trials in Uganda, the safety and efficacy of pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine/tenofovir in reducing HIV acquisition.

  • Funding Partners: University of Washington
  • Program Partners: The AIDS Support Organization-Mbale and Tororo, Uganda; CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Reducing HIV Acquisition through PrEP - Uganda

Research Fellowships for FETP Graduates

To help CDC provide technical assistance and expertise to support the African Programme for Advanced Research Epidemiology Training, a program that provides fellowships and research grants to graduates of Field Epidemiology Training Programs (FETPs).

  • Funding Partners: European Union
  • Program Partners: CDC's Center for Global Health

> Research Fellowships for FETP Graduates

Road Traffic Injury Prevention and Control in India

To work closely with partners in India to develop, implement, evaluate and disseminate evidence-based interventions to address the critical issue of occupational and non-occupational road safety and trauma care and to promote road traffic injury prevention.

 

  • Funding Partners: Conrad N. Hilton Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Road Traffic Injury Prevention and Control in India

Roadmap for Road Traffic Injury Prevention and Control in India

To convene an expert panel of Indian and U.S. public health officials, scientists and policy makers to outline critical next steps toward a comprehensive road traffic injury prevention and control initiative in India.

  • Funding Partners: General Motors Foundation
  • Program Partners: India Ministry of Health and Family Welfare; CDC's National Center for Injury Prevention and Control

> Roadmap for Road Traffic Injury Prevention and Control in India

Rotavirus and Pneumococcal Vaccination

To help determine how rotavirus and pneumococcal vaccines could be improved for use in developing countries and to provide evidence on the current impact and effectiveness of these vaccines to help countries make informed decisions about vaccine adoption.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus and Pneumococcal Vaccination

Rotavirus Breast Milk Analysis

To collect breast milk from mothers in developing countries with infants less than 6 months of age in order to examine levels of antibody response to rotavirus and compare the inhibitory effect of maternal antibody on vaccine strains.

  • Funding Partners: Centers for Disease Control and Prevention
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Breast Milk Analysis

Rotavirus Intussusception Surveillance in South Africa

To initiate a network of South African hospitals to conduct intussusception surveillance and apply the resource-efficient and scientifically sound case-series analysis to generate vital evidence for monitoring the safety of rotavirus vaccine use.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> Rotavirus Intussusception Surveillance in South Africa

Rotavirus Journal Supplement on Vaccines in India

To collaborate with local experts and institutions in India, including the Ministry of Health and Family Welfare (MOHFW) and the Indian Council of Medical Research (ICMR), on the production of a journal supplement focused on rotavirus diarrhea and vaccine in India.

  • Funding Partners: Bill and Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Journal Supplement on Vaccines in India

Rotavirus Surveillance

To allow countries, primarily in Asia and Africa, to continue rotavirus surveillance activities in anticipation of the introduction of the rotavirus vaccine.

  • Funding Partners: GlaxoSmithKline Biologicals s.a.; Merck Sharp & Dohme Corp.;
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Surveillance

Rotavirus Surveillance in Ghana and Rwanda

To determine, following the introduction of the rotavirus vaccine in Ghana and Rwanda, the impact of the vaccine on rotavirus cases and on diarrhea morbidity from all causes.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Surveillance in Ghana and Rwanda

Rotavirus Vaccine in Developing Countries

To develop evidence for improving the performance of live, attenuated, orally delivered rotavirus vaccines in infants in the developing world.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Vaccine in Developing Countries

Rotavirus Vaccine Intussusception Surveillance

To develop a network of intussusception surveillance in 6-7 countries planning to adopt rotavirus vaccination in 2012-2014. A key issue for the wide, sustained use of rotavirus vaccines is the demonstration of safety, especially with regard to intussusception, a serious but uncommon intestinal blockage.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Vaccine Intussusception Surveillance

Safe Delivery for Mothers in Kenya

To help CDC and its partners in rural western Kenya provide transportation to a healthcare facility for expecting mothers and ensure that women giving birth in a facility or at home have access to a safe delivery kit and blood supply.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Safe Delivery for Mothers in Kenya

Stephen B. Thacker Fund

To honor Dr. Thacker's life and service to public health as well as his passion for the Epidemic Intelligence Service. Established by the Thacker Family through the CDC Foundation.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's Office of Surveillance, Epidemiology and Laboratory Services

> Stephen B. Thacker Fund

Strengthening Disease Surveillance and Response in Central Africa

To strengthen disease surveillance and response programs in select Central African countries.

  • Funding Partners: The Bill & Melinda Gates Foundation
  • Program Partners: World Health Organization; CDC's Center for Global Health; CDC's National Center for Immunization and Respiratory Diseases

> Strengthening Disease Surveillance and Response in Central Africa

Sylvatic Reservoirs of Human Monkeypox

To improve understanding of how Monkeypox viruses are transmitted among mammals and humans in Africa.

  • Funding Partners: University of Wisconsin, Madison; The Field Museum of Natural History
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infections

> Sylvatic Reservoirs of Human Monkeypox

Together for Girls

To enable CDC to work with individual countries and regions to quantify the problem of sexual violence against girls and subsequently develop evidence-based policies and programs to protect children and prevent violence.

  • Funding Partners: United Nations Population Fund, Nduna Foundation
  • Program Partners: BD; Clinton Global Initiative; Grupo ABC; PEPFAR; United Nations Development Programme; U.S. Department of State; CDC's National Center for Injury Prevention and Control

> Together for Girls

Trachoma and Lymphatic Filariasis in Mali

To research programs that will contribute to the development of a fully integrated, sustainable and scalable comprehensive control program for trachoma and lymphatic filariasis in Mali.

  • Funding Partners: Task Force for Global Health; International Trachoma Initiative
  • Program Partners: Mali Ministry of Health; CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Trachoma and Lymphatic Filariasis in Mali

Vaccine Induced Immune Responses to Plasmodial Antigens

To support an immunization and challenge trial of CDC’s P. falciparum chimeric MSP1/8 vaccine in nonhuman primates. The specific model will involve studies in the monkey species Aotus nancymaae using the P. falciparum FVO strain.

  • Funding Partners: Drexel University, National Institutes of Health (NIH)
  • Program Partners: CDC's Center for Global Health

> Vaccine Induced Immune Responses to Plasmodial Antigens

Vaccine Research and Surveillance

To conduct vaccine research and surveillance with several countries to determine the burden of vaccine preventable diseases, including meningitis, pneumonia, intussusception and rubella. The partnership will enhance the quality of disease and coverage data and assess vaccine impact.

  • Funding Partners: GAVI Alliance
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases; CDC’s Center for Global Health

> Vaccine Research and Surveillance

Chronic Disease & Birth Defects

Heart disease, cancer, diabetes, childhood asthma, obesity and other chronic conditions that affect us — and those we care about — now account for 70 percent of all deaths in the United States. Racial, ethnic and socioeconomic health disparities persist and widen. While CDC is best-known for fighting infectious disease outbreaks, CDC also provides the science that helps community leaders, employers and families battle chronic health threats by choosing and promoting healthy behaviors. The CDC Foundation helps connect CDC with foundations and businesses in the private sector that have a shared interest in promoting healthy life styles and preventing chronic diseases.

Chronic Disease & Birth Defects Programs

Biomarkers of Infertility

To study biomarkers of infertility in 750 women trying to conceive over 12 months. CDC will perform a sample analysis and advise on the study design, sample collection and data analyses, measuring FSH and the estrogen metabolite, estrone 3-glucuronide, for standardized pregnancy determination. 

  • Funding Partners: University of North Carolina at Chapel Hill
  • Program Partners: CDC's National Center on Birth Defects and Developmental Disabilities

> Biomarkers of Infertility

Colorectal Cancer Screening

To focus on the integration of colorectal cancer screening with other chronic disease programs that provide screening and diagnostic services to U.S. adults.

  • Funding Partners: American Cancer Society
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Colorectal Cancer Screening

Distinguished Alcohol Research Fellows

To provide up to three Distinguished Alcohol Research Fellows to help CDC improve public health surveillance on excessive alcohol use by conducting applied public health research, supporting state and local public health capacity in alcohol epidemiology, and supporting the translation of Community Guide recommendations for the prevention of excessive drinking into public health practice.

  • Funding Partners: CDC
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Distinguished Alcohol Research Fellows

Early Assessment of Childhood Obesity

To identify ongoing interventions aimed at reducing childhood obesity that successfully reduce children's body mass indices.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Early Assessment of Childhood Obesity

Early Childhood Mortality Collaboration

To help CDC's Newborn Screening Branch collaborate with California's newborn screening program through the ongoing Early Childhood Mortality Collaborative Project.

  • Funding Partners: The Evanosky Foundation
  • Program Partners: CDC's Division of Laboratory Sciences

> Early Childhood Mortality Collaboration

Evaluation of Program Impact Through PRAMS

To facilitate a collaboration between CDC and the Kellogg Foundation to assess the potential impact of Kellogg-supported interventions through the use of CDC's Pregnancy Risk Assessment Monitoring System (PRAMS). PRAMS collects state-specific, population-based data on maternal attitudes and experiences before, during, and shortly after pregnancy. 

  • Funding Partners: W.K. Kellogg Foundation
  • Program Partners: CDC's Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion

> Evaluation of Program Impact Through PRAMS

Healthy People 2020 Law and Health Policy Project

To develop progress reports linked to Healthy People 2020 (a science-based, 10-year national objective for improving the health of Americans) to demonstrate the value of legal and policy interventions in improving Americans' health.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's Office of the Associate Director for Program and Division for Heart Disease and Stroke Prevention

> Healthy People 2020 Law and Health Policy Project

Heart Disease and Stroke Prevention Campaign

To develop a national cardiovascular prevention campaign in alliance with the Million Hearts® initiative and the Division for Heart Disease and Stroke Prevention to encourage more Americans to engage with their healthcare providers to address the “ABCs” of heart health and identify lifestyle behaviors that could increase the risk of cardiovascular disease and stroke.

  • Funding Partners: Pfizer
  • Program Partners: CDC’s Division for Heart Disease and Stroke Prevention

> Heart Disease and Stroke Prevention Campaign

Hormone Laboratory Collaborations

To help CDC provide reference and quality control materials for laboratory collaboration, including collaborations for the Hormone Measurement Standardization program.

  • Funding Partners: AB SCIEX; ARUP Laboratories; Boston Medical Center; College of American Pathologists; College of American Pathologists Foundation; Endocrine Sciences Inc.; Esoterix, Inc; LA Biomed; Quest Diagnostics Incorporated; Roche Diagnostic Systems, Inc.; Taylor Technology, Inc.; Tosoh Corporation
  • Program Partners: CDC's Division of Laboratory Sciences

> Hormone Laboratory Collaborations

Improving Health Outcomes of LGBT Youth

To address critical gaps in knowledge about protective factors (e.g., parental acceptance, family and school connectedness) and interventions that promote positive health outcomes among lesbian, gay, bisexual and transgender (LGBT) youth, and to possibly improve academic and social outcomes in this population. This project will result in the development and dissemination of publications and other resources that enhance the scientific and programmatic response to HIV, STDs, and other sexual health issues among LGBT youth.

  • Funding Partners: Arcus Foundation
  • Program Partners: CDC’s Division of Adolescent and School Health

> Improving Health Outcomes of LGBT Youth

Laboratory Surveillance for Factor XIII Deficiency

To provide support for Factor XIII testing to accurately diagnose patients in the United States in order to enhance the surveillance of rare bleeding disorders.

  • Funding Partners: Novo Nordisk Inc.
  • Program Partners: CDC’s National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders

> Laboratory Surveillance for Factor XIII Deficiency

Newborn Screening Test for Spinal Muscular Atrophy

To facilitate collaborative development of a newborn bloodspot screening test to detect the genetic lesions that cause spinal muscular atrophy. The test will be designed to use in public health newborn screening laboratories.

  • Funding Partners: Biogen
  • Program Partners: CDC’s Division of Laboratory Sciences

> Newborn Screening Test for Spinal Muscular Atrophy

Newborn Screening Translation Research Initiative

To improve four major areas of newborn screening: 1) developing new screening methods for specific diseases, 2) integrating state public health laboratories in the translation process through collaborative field studies, 3) expanding the global reach of newborn screening, and 4) adapting innovative technologies for screening and quality assurance.

  • Funding Partners: Genzyme Corporation; Applied Biosystems; Brown University; The Miriam Hospital; National Alliance for Autism Research; New York State Department of Health; The Evanosky Foundation; USA Medical Research and Materiel Command
  • Program Partners: Jeffrey Modell Foundation; Johns Hopkins Bloomberg School of Public Health; Kennedy Krieger Institute; Medical College of Georgia; The University of Texas at San Antonio; University of Washington; Washington State Department of Health; Wisconsin State Laboratory of Hygiene; CDC’s Division of Laboratory Sciences

> Newborn Screening Translation Research Initiative

Planes, Trains and Auto-mobility

To increase walking in the Atlanta Hartsfield-Jackson International Airport using motivational signage to encourage passengers to walk from the terminal to their concourse rather than ride the airport train.

  • Funding Partners: The Kresge Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Planes, Trains and Auto-mobility

Study of Blood Inhibitors in Hemophilia Patients

To monitor hemophilia patients for the development of inhibitors and establish a surveillance system to collect and analyze a uniform set of clinical data.

  • Funding Partners: Baxter International, Inc.; Pfizer Inc
  • Program Partners: CDC's National Center on Birth Defects & Developmental Disabilities

> Study of Blood Inhibitors in Hemophilia Patients

Testosterone Measurement Harmonization

To improve and standardize testosterone measurements to help provide better medical care to people with impaired androgen levels and people receiving androgen therapy.

  • Funding Partners: Abbott Products, Inc. (formerly Solvay Pharmaceuticals, Inc.)
  • Program Partners: CDC's Division of Laboratory Sciences

> Testosterone Measurement Harmonization

The Impact of Smoke-free Policies on Restaurants and Bars

To increase business-sector support for comprehensive smoke-free policies by building a business case for smoke-free environments that shows the economic impact of such policies and by facilitating business-to-business and peer-to-peer sharing of experiences, perspectives and associated outcomes of such policies.

  • Funding Partners: Pfizer Inc
  • Program Partners: CDC's Office on Smoking and Health

> The Impact of Smoke-free Policies on Restaurants and Bars

Tobacco Network Lab Fellowship

To support a fellow in CDC's Division of Laboratory Sciences to help the Tobacco Laboratory Network address testing and research of tobacco products at the global level in accordance with the tobacco product regulation provisions outlined by the WHO Framework Convention on Tobacco Control.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's Division of Laboratory Sciences

> Tobacco Network Lab Fellowship

Understanding Barriers to Breast Cancer Screening

To examine spatial and temporal accessibility to mammography facilities for residents living in economically disadvantaged areas in the Atlanta metropolitan area using GIS (Geographic Information Systems) methods.

  • Funding Partners: Susan G. Komen for the Cure
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) & National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ATSDR)

> Understanding Barriers to Breast Cancer Screening

Infectious Disease

Many infections, once though conquered, have reemerged in drug-resistant forms. Globalization — from air travel to food production — has opened new doors for bacteria and viruses to enter the U.S. One of CDC's most visible roles is identifying and controlling outbreaks of infectious diseases and protecting us from emerging infectious threats. The CDC Foundation provides opportunities for outside partners to support CDC's efforts and join in the fight.

Infectious Disease Programs

Antimicrobial Education for Medical Students

To develop and implement a survey of medical students assessing their knowledge of antimicrobial use and resistance as well as their perceptions of how much education they are getting to prescribe antimicrobials wisely.

  • Funding Partners: Merck
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Antimicrobial Education for Medical Students

Antimicrobial Stewardship Programs

To demonstrate the efficacy of an antimicrobial stewardship project in long-term care facilities using the syndromic approach targeting urinary tract infections.

  • Funding Partners: Merck
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Antimicrobial Stewardship Programs

Aspergillus Susceptibility to Echinocandin

To describe the MIC, MEC and prevalence of resistance to echinocandin drugs among a large collection of Aspergillus isolates and to compare these resistance patterns to previous reports.

  • Funding Partners: Merck Sharp & Dohme Corp.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infections

> Aspergillus Susceptibility to Echinocandin

Birth Cohort Hepatitis Evaluation (BEST-C)

To screen and test for hepatitis C, employing randomized controlled designs to implement and evaluate the birth cohort testing strategy in three large primary care settings. The study will evaluate the association between birth cohort screening and clinical outcomes, by tracking patients identified through the study and observing them from the entry into care to subsequent achievement of sustained virologic response.
  • Funding Partners: AbbVie
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Birth Cohort Hepatitis Evaluation (BEST-C)

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

To support the Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C (BEST-C) project, a two-year study that will evaluate the effectiveness of screening all persons born from 1945 to 1965  for Hepatitis C (HCV) in order to increase the proportion of people who are aware of their HCV status.

  • Funding Partners: Genentech, A Member of the Roche Group; Merck Sharp & Dohme; Janssen Pharmaceutical Companies of Johnson & Johnson; Vertex Pharmaceuticals; AbbVie, Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

CHeCS Cost-effectiveness Modeling Fellow

To increase CDC's capacity to better understand the cost-effectiveness of the different screening, treatment and care options that are now available for persons living with viral hepatitis.

  • Funding Partners: Bristol-Myers Squibb
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> CHeCS Cost-effectiveness Modeling Fellow

Chronic Hepatitis B and C Cohort Study

To establish the first comprehensive U.S. longitudinal observational cohort of 15,000 or more patients with chronic viral hepatitis B and C in order to improve understanding of chronic viral hepatitis and the impact of screening, care and treatment recommendations.

  • Funding Partners: Abbott Laboratories; Genentech, A Member of the Roche Group; Janssen Pharmaceutical Companies of Johnson & Johnson; and Vertex Pharmaceuticals
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Chronic Hepatitis B and C Cohort Study

Clostridium Difficile Infection Surveillance

To identify groups at high risk of Clostridium difficile infection (CDI) to be targeted for vaccine using two potential vaccination scenarios in order to create a CDI risk index and identify surrogates for inpatient antibiotic exposure. This study will use hospital administrative data, hospital pharmacy data and CDI data from hospitalized patients at two large academic centers participating in the Emerging Infections Program (EIP).

  • Funding Partners: GlaxoSmithKline
  • Program Partners: CDC’s Division of Preparedness and Emerging Infections

> Clostridium Difficile Infection Surveillance

Control of Cytomegalovirus (CMV) by Cell-Type-Specific Neutralizing Antibodies

To develop strategies to control cytomegalovirus (CMV) congenital infection, which affects as many as 10,000 children per year in the U.S.

  • Funding Partners: Georgia Research Alliance
  • Program Partners: Emory University, CDC's National Center for Immunization and Respiratory Diseases

> Control of Cytomegalovirus (CMV) by Cell-Type-Specific Neutralizing Antibodies

Controlling Viral Foodborne Disease

To help CDC collaborate with the U.S. Department of Agriculture and the National Institute of Food and Agriculture to create an integrated, multi-disciplinary approach to developing improved tools, skills and capacity to study foodborne viruses. Outcomes of the partnership will be used to systematically identify risk factors and develop risk management strategies to reduce contamination in pre- and post-harvest environments.

  • Funding Partners: North Carolina State University
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Controlling Viral Foodborne Disease

Crimean Congo Hemorrhagic Fever

To create a multidisciplinary research activity that will improve basic knowledge of Crimean Congo Hemorrhagic Fever virus biology, pathogenesis, vaccine development, and therapeutic and integrated control measures.

  • Funding Partners: European Commission
  • Program Partners: INSERM, CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Crimean Congo Hemorrhagic Fever

Crimean-Congo Hemorrhagic Fever Study

To research the nairovirus, Crimean-Congo hemorrhagic fever, a tick-borne viral disease, especially common in East and West Africa. With mortality rates as high as 80% and with no FDA approved vaccines or therapeutics, Crimean-Congo hemorrhagic fever is considered a dangerous pathogen and a serious bioterrorism threat. The project will expand the knowledge of the ovarian tumor (OTU) protease domain of the nairovirus to inform control measures and vaccine development.

  • Funding Partners: University of Denver
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Crimean-Congo Hemorrhagic Fever Study

Development of Inactivated Polio Vaccine Strains

To develop a genetically stable inactivated poliovirus vaccine.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Development of Inactivated Polio Vaccine Strains

Dual Compartment Microbicide to Prevent HIV Transmission

To support the development of a safe and effective dual compartment microbicide to be applied either vaginally or rectally as pre-exposure prophylaxis (PrEP) against the transmission of HIV.

  • Funding Partners: ImQuest Life Sciences, Inc.
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

> Dual Compartment Microbicide to Prevent HIV Transmission

Effects of Ultraviolet Light

To measure the effects of monochromatic ultraviolet light on viral specimens.

  • Funding Partners: University of Colorado at Boulder
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Effects of Ultraviolet Light

Epithelial Cell Proliferation Assay Development

To provide synthetic peptides for a study on epithelial cell proliferation.

  • Funding Partners: Practakal LLC
  • Program Partners: CDC's Office of Infectious Diseases

> Epithelial Cell Proliferation Assay Development

Evaluation of Jet Injectors for Delivery of MMR Vaccine

To help CDC conduct bench tests to evaluate the effect of Disposable-syringe jet injectors on measles, mumps and rubella (MMR) vaccine stability. The work is part of the larger Disposable Syringe Jet Injector project, which is led by PATH and supported by the Bill & Melinda Gates Foundation.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Evaluation of Jet Injectors for Delivery of MMR Vaccine

Evaluation of RSV Therapeutic Antibodies

To evaluate whether two novel, candidate human anti-RSV G monoclonal antibodies have the ability to reduce or attenuate disease pathogenesis in the mouse model for acute RSV infection.

  • Funding Partners: Trellis Bioscience
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Evaluation of RSV Therapeutic Antibodies

Evaluation of the Meningicoccal Vaccine

To evaluate the effect of meningococcal conjugate vaccine on "herd immunity" in adolescent communities.

  • Funding Partners: Sanofi Pasteur, Inc.
  • Program Partners: Georgia Department of Human Resources, Maryland Department of Health and Mental Hygiene, CDC's Office of Infectious Diseases

> Evaluation of the Meningicoccal Vaccine

Foodborne Illness Prevention

To increase collaboration across the country and across relevant areas of expertise to reduce foodborne illness in the United States.

  • Funding Partners: YUM! Brands, Inc.
  • Program Partners: CIFOR, CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Foodborne Illness Prevention

Genomic Epidemiology of Neisseria Gonorrhoeae

To study demographic data and Neisseria gonorrhoeae isolates collected as part of the Gonococcal Isolate Surveillance Project and to look at within-host diversity in an ongoing study of extra- genital gonococcal infection.

  • Funding Partners: The Brigham and Women’s Hospital
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Genomic Epidemiology of Neisseria Gonorrhoeae

Get Smart: Know When Antibiotics Work

To support the CDC's national campaign to promote discriminating use of antimicrobial agents. The campaign seeks to change behavior that leads to overuse of antimicrobial agents in adult and pediatric patients.

  • Funding Partners: Abbott Laboratories; Advanstar Communications, Inc.; Aventis Pharmaceuticals; Bayer AG; Daiichi Pharmaceuticals Co., Ltd.; GlaxoSmithKline; Hoffmann-LaRoche, Inc.; Ortho-McNeil Pharmaceutical, Inc.; Pfizer Inc
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Get Smart: Know When Antibiotics Work

Global Burden of Foodborne Norovirus

To estimate incidence rates of gastroenteritis due to norovirus by age and country/WHO region, taking; to describe and quantify the available data on health effects resulting from these infections; to estimate the proportion of norovirus that is foodborne; and to provide a critical appraisal of data gaps.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Global Burden of Foodborne Norovirus

Healthy Swimming

To raise awareness about preventing recreational water illness such as diarrhea and skin, ear, and eye infections.
  • Funding Partners: National Swimming Pool Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Healthy Swimming

HHV-8 in HIV+ Organ Transplantation Patients

To test clinical specimens from HIV+ patients following solid organ transplantation to evaluate human herpesvirus-8 (HHV-8)-associated complications and disease. The purpose of the study is to provide information regarding HIV-specific risks of transplantation and to aid the clinician in balancing immunosuppressive and anti-viral medications following transplantation to maximize outcomes in this patient population.

  • Funding Partners: University of California, San Francisco (UCSF)
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> HHV-8 in HIV+ Organ Transplantation Patients

HPV Genotyping and Immunogenicity Measures

To enable CDC to provide technical and analytical expertise in HPV genotyping and immune response measurements to academic and other partners in need of these assays to advance public health objectives related to HPV vaccine impact monitoring and HPV epidemiology.

  • Funding Partners: University of Puerto Rico
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> HPV Genotyping and Immunogenicity Measures

Immunologic and Genetic Markers in Norovirus

To improve the understanding of the human immune response and genetic factors associated with norovirus (NoV) infection as well as viral load and level of immunity against subsequent NoV outbreaks. CDC will collaborate with the State Public Health Division, affiliated local health departments and long-term care facilities in this study.

  • Funding Partners: Takeda Pharmaceuticals
  • Program Partners: CDC’s National Center for Infectious Diseases and Oregon Public Health Division

> Immunologic and Genetic Markers in Norovirus

Improving Pneumococcal Vaccine

To compare the immunogenicity of current vaccines for pneumococcal disease (native pneumococcal polysaccharide vaccine) with a proposed new vaccination method (microsphere entrapped pneumococcal capsular polysaccharides delivered either subcutaneously or intranasally).

  • Funding Partners: Georgia Research Alliance
  • Program Partners: Emory University, Mercer University, CDC's National Center for Immunization and Respiratory Diseases

> Improving Pneumococcal Vaccine

Improving the Measles Vaccine

To provide laboratory support for the development of a more thermostatable measles vaccine.

  • Funding Partners: Universal Stabilization Technologies Inc.
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Improving the Measles Vaccine

Invasive MRSA among Recent Acute Care Patients

To identify risk factors for developing invasive MRSA infection after being discharged from an acute care hospital and to identify a subset of patients who may benefit from targeted interventions.

  • Funding Partners: Stiefel Laboratories, Inc. (a GlaxoSmithKline company)
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Invasive MRSA among Recent Acute Care Patients

Malaria Research and Reference Reagent Repository

To support a mosquito stock repository that supplies living and preserved laboratory cultured malaria-vector mosquitoes to researchers studying malaria.

  • Funding Partners: American Type Culture Collection; The Rockefeller University; Snell Scientifics, LLC; SpringbornSmithers Laboratories; University of California; University of Florida; University of Illinois at Urbana-Champaign
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Malaria Research and Reference Reagent Repository

Monitoring Malaria Treatment in the U.S.

To collect, manage and analyze data on the safety and efficacy of artemether/lumefantrien used to treat cases of malaria in the U.S.

 

  • Funding Partners: Novartis Pharmaceuticals Corporation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Monitoring Malaria Treatment in the U.S.

Multistate Fungal Meningitis Outbreak Management

To respond to an unprecedented outbreak of central nervous system, joint and osseous mold infections that have been observed, beginning in August of 2012, among hundreds of patients who received contaminated methylprednisolone injections. This project will collect long-term follow-up data on diagnosis and appropriate treatment of fungal meningitis and other fungal infections associated with this outbreak in order to fully understand and track the burden of these infections.

  • Funding Partners: Gilead Sciences, Inc.
  • Program Partners: CDC’s National Center for Emerging and Infectious Zoonotic Diseases

> Multistate Fungal Meningitis Outbreak Management

National Hepatitis Education Campaign

To raise awareness about chronic viral hepatitis and increase the number of people who are tested for it.

  • Funding Partners: Merck; Vertex Pharmaceuticals, Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> National Hepatitis Education Campaign

Neglected Burden of Human Vivax Malaria

To work with CDC's Division of Parasitic Diseases to study seven P. vivax isolates to sequence P. vivax DNA and RNA.

  • Funding Partners: The Massachusetts Institute of Technology
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Neglected Burden of Human Vivax Malaria

Norovirus In-Vitro Time-Kill Evaluation

To evaluate commercial sanitizing products for their virucidal effectiveness against murine norovirus.

  • Funding Partners: Arch Chemicals, Inc.; GOJO Industries, Inc.; Holland America Line; IISES, LLC; Indusco Distribution of America, Inc.; International Atomic Energy Agency; LigoCyte Pharmaceuticals; Microbide Limited; Mölnlycke Health Care, LLC; Oxoid Ltd.; Pathcon Laboratories; Procter & Gamble Company; RADCO Chemical Solutions, Inc.; R-Biopharm Inc.; Remel Inc.; The University of Queensland, Australia
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Norovirus In-Vitro Time-Kill Evaluation

NYC Hanes Lab Study

To conduct hepatitis B, C and E testing on blood specimens in partnership with the Department of Health and Mental Hygiene of the City of New York.

  • Funding Partners: Fund for Public Health in New York
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; Department of Health and Mental Hygiene of the City of New York

> NYC Hanes Lab Study

Organ Transplant Infection Prevention Project

To create a repository of specimens associated with infections of patients who are enrolled in the study. The project will also determine the markers that predict the occurrence of invasive fungal infections and their resistance to antimicrobials.

  • Funding Partners: Merck & Co.; Gilead; Pfizer
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Organ Transplant Infection Prevention Project

Pediatric HIV/AIDS Cohort Study

To follow the long-term effects of anti-retroviral treatment on children who are perinatally infected with HIV and to understand measles, mumps and rubella antibody responses in these children.

  • Funding Partners: Tulane University
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Pediatric HIV/AIDS Cohort Study

Point-of-Care Diagnostics for Norovirus

To help CDC collaborate in a larger norovirus study by developing glycan-based assays to evaluate a panel of different synthetic glycans as well as naïve norovirus stool strains.

  • Funding Partners: Georgia State University
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Point-of-Care Diagnostics for Norovirus

Prevent Antimicrobial Resistance in Healthcare Setting

To develop a series of health communications aimed at increasing awareness among physicians of CDC's goals of preventing the spread of antimicrobial resistance. The goal of this initiative is to develop an integrated program to prevent emergence and spread of antimicrobial-resistant infections among patients in healthcare settings.

  • Funding Partners: BD; Cubist Pharmaceuticals; Warren Y. Jobe; Kimberly-Clark; Ortho-McNeil Pharmaceutical, Inc.; Premier, Inc.; Pfizer Inc; University of Alabama at Birmingham; Vermont Oxford Network, Inc.; Wellpoint Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Prevent Antimicrobial Resistance in Healthcare Setting

Preventing Infections in Cancer Patients

To develop a comprehensive education campaign targeting cancer patients, their families and their providers to reduce the risk of infection in multiple settings (outpatient office, hospital and home).

  • Funding Partners: Amgen
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion, CDC's National Center for Emerging and Zoontic Infectious Diseases

> Preventing Infections in Cancer Patients

Production of Rabies Virus Antigens in Rice

To help CDC collaborate in the development of a new rice-based rabies vaccine that has the potential to be safer and less expensive than current oral rabies vaccines. CDC will help develop four recombinant plasmid constructs to express rabies virus glycoprotein and a derivative mutant which is more immunogenic, and, after expression analysis, CDC will evaluate rice grain expressing rabies viral antigens in a mouse model to determine its effectiveness in eliciting a neutralizing antibody response.

  • Funding Partners: Ventria Biosciences, Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Production of Rabies Virus Antigens in Rice

Rabies Prevention Symposium

To educate professionals in the fields of emergency medicine, pediatrics, infectious disease, public health, animal control, etc. about appropriate rabies prevention protocols.

  • Funding Partners: Novartis Vaccines and Diagnostics, Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Rabies Prevention Symposium

Rabies Vaccine Stabilization

To test the potency, safety, immunogenicity and efficacy of new rabies vaccine stabilization formulations. 

  • Funding Partners: Universal Stabilization Technologies Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Rabies Vaccine Stabilization

Rift Valley Fever Virus Vaccination Development

To assist in the development of novel vaccines and comprehensive strategies for the prevention of Rift Valley Fever virus in both livestock and humans using recombinant proteins and 96-well ELISA or Luminex platforms to detect anti-NP, anti-NSs or anti-NSm antibodies.

  • Funding Partners: National Center for Foreign Animal and Zoonotic Disease Defense (FAZD Center)
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Rift Valley Fever Virus Vaccination Development

Safe Injection Practices Coalition

The Safe Injection Practices Coalition is a partnership of healthcare-related organizations, patient advocacy organizations, industry partners and other public health partners, led by the Centers for Disease Control and Prevention that was formed to promote safe injection practices in all U.S. healthcare settings. The Coalition has developed the One & Only Campaign – a public health education and awareness campaign – aimed at both healthcare providers and patients to advance and promote safe injection practices.

  • Funding Partners: multiple organizations
  • Program Partners: Accreditation Association for Ambulatory Health Care, Inc. (AAAHC); American Association of Nurse Anesthetists (AANA); Association for Professionals in Infection Control and Epidemiology, Inc (APIC); American Society for Healthcare Risk Management (ASHRM); Association of State and Territorial Health Officials (ASTHO); Centers for Disease Control and Prevention (CDC); Eli Lilly and Company; HONOReform Foundation; Institute for Safe Medication Practices (ISMP); National Association of County & City Health Officials (NACCHO); Premier Safety Institute, Society of Gastroenterology Nurses and Associates (SGNA); The Society for Healthcare Epidemiology of America (SHEA); U.S. Food and Drug Administration – Safe Use Initiative (Advisor)

> Safe Injection Practices Coalition

Smallpox Zero Reminiscences Project

To help the Edward Jenner Museum, Berkeley, UK, collaborate with the David J. Sencer CDC Museum to record smallpox eradication experiences and collect memorabilia worldwide.

  • Funding Partners: Marguerite Casey Foundation
  • Program Partners: David J. Sencer CDC Museum

> Smallpox Zero Reminiscences Project

Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study

To learn lessons about how best to incorporate the delivery of daily oral pre-exposure prophylaxis (PrEP) into the services provided by health centers serving sexually active adults at high risk of acquiring HIV infection. The pilot study will initiate data collection at federally-qualified health centers (FQHCs) or look-alikes in four U.S. cities.

  • Funding Partners: Gilead Sciences, Inc.
  • Program Partners: CDC’s Division of HIV/AIDS Prevention, Central Care Community Health Center, Strawberry Mansion Health Center, Access Community Health Network – Grand Boulevard Clinic, Newark Community Health Centers, Inc., University of Colorado

> Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study

Synthesis of XMRV Peptides

To develop a mass spectrometry method that can be used to identify and quantify a novel protein produced by the prostate-cancer-associated retrovirus XMRV in patient samples.

  • Funding Partners: Emory University School of Medicine
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infections

> Synthesis of XMRV Peptides

Testing with the Dengue Multiplex PCR Assay

To test coversing the quantization in epidemiological trial EDNEI human serum samples.

  • Funding Partners: Sanofi Pasteur, Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Testing with the Dengue Multiplex PCR Assay

The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections

To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.

  • Funding Partners: The Sally Schieffein Potter Endowment; multiple individuals and organizations
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections

Treatment of TB with Priftin (rifapentine)

To continue the research and development of the drug Priftin® (rifapentine) and to investigate its role in the treatment of active tuberculosis (TB) disease and latent TB infection.

  • Funding Partners: Sanofi-Aventis
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Treatment of TB with Priftin (rifapentine)

Vertebral Fracture Assessment in NHANES

To add vertebral fracture assessment (VFA) to the 2013-2014 National Health and Nutrition Examination Survey (NHANES) using lateral spine dual-energy X-ray absorptiometry (DXA) scans, anterior-posterior (AP) spine and femur DXA scans for bone mineral density (BMD) and a Fracture Risk Assessment Tool (FRAX) which includes questions related to osteoporosis and fractures.

  • Funding Partners: Eli Lilly and Company
  • Program Partners: CDC’s National Center for Health Statistics

> Vertebral Fracture Assessment in NHANES

Viral Hepatitis Action Coalition

To provide an overall framework for organizations concerned with viral hepatitis to support high priority research, education and program evaluation projects initiated by CDC's Division of Viral Hepatitis.

  • Funding Partners: Abbott Laboratories; AbbVie; Alere; Bayer HealthCare; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech, A Member of the Roche Group; Gilead Sciences, Inc.; GlaxoSmithKline; Janssen Therapeutics; Kadmon; Merck Sharp & Dohme; Onyx Pharmaceuticals; OraSure Technologies; Quest Diagnostics; Vertex Pharmaceuticals, Inc.
  • Program Partners: National Viral Hepatitis Roundtable; CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Viral Hepatitis Action Coalition

Viral Variants for Rabies Research and Interventions

To generate infectious rabies virus variants from naturally infected animals which can then be used in rabies research designed to improve disease prevention after exposure as well as intervention after disease onset.

  • Funding Partners: The University of Texas Medical Branch
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Viral Variants for Rabies Research and Interventions

VZV Antibody Response in HIV-Infected Children

To assess the antibody response to varicella-zoster virus (VZV) among school-aged perinatally HIV-infected children and youth to help inform public health officials whether anti-retroviral treatment positively affects both the duration and the level of the antibody response to vaccination in early years following HIV infection. CDC will conduct varicella IgG testing from sera obtained from participants in the Pediatric HIV/AIDS Cohort Study. Findings should indicate whether there is a need to vaccinate these children again.

  • Funding Partners: Tulane University
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> VZV Antibody Response in HIV-Infected Children

Zooster Vaccine and Postherpetic Neuralgia

To help CDC participate in a larger research collaboration on zooster vaccine.
  • Funding Partners: Kaiser Permanente
  • Program Partners: CDC’s Division of Viral Diseases

> Zooster Vaccine and Postherpetic Neuralgia

Injury & Violence

Preventable injury and violence are leading causes of death and disability. On one end of the spectrum, homicide is the second leading cause of death among young people between the ages of 10 and 24 years old. At the other end, falls are the leading cause of injury deaths and emergency room visits for seniors. CDC works to prevent unintentional injuries – from car crashes to senior falls – as well as injuries and death resulting from violence. The CDC Foundation helps connect CDC to outside partners that share CDC's goals of reducing injury- and violence-related death and disability through prevention.

Injury & Violence Programs

Adaptation of Evidence-based Interventions in Violence Prevention

To help CDC study how community-based organizations adapt evidence-based interventions and whether or not those adaptations make the programs more or less effective. The initial study will focus on violence prevention programs, but researchers at CDC believe the outcomes of the research will be relevant to other public health issues and programs.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Adaptation of Evidence-based Interventions in Violence Prevention

Building Networks for Health Equity: The Breakthrough Initiative

The Breakthrough Initiative is a collaborative effort between the National Association of County and City Health Officials (NACCHO), the Healthy Heartlands Coalition of faith-based community organizations and CDC’s Division of Violence Prevention. The Breakthrough Initiative is designed to intervene on inequities in health and safety through the development of networks and collaborative actions between local public health agencies and faith-based community organizations.

  • Funding Partners: W.K. Kellogg Foundation
  • Program Partners: CDC’s Division of Violence Prevention, National Association of County and City Health Officials (NACCHO), Healthy Heartlands Coalition of faith-based community organizations

> Building Networks for Health Equity: The Breakthrough Initiative

Early Childhood and Health Inequities Engagement and Awareness Campaign

To support the dissemination of The Raising of America, a documentary series and multimedia initiative that reframes the way we look at early child health and development. This two-year national public engagement and education initiative aims to prevent child maltreatment and achieve health equity by improving social and economic conditions for all children and their families.

  • Funding Partners: Doris Duke Charitable Foundation
  • Program Partners: CDC’s National Center for Injury Prevention and Control, Division of Violence Prevention

> Early Childhood and Health Inequities Engagement and Awareness Campaign

Evaluation of UPS’s Road Code Teen Driving Program

To conduct a program analysis and evaluation of United Parcel Service’s (UPS) Road Code, an interactive program that brings UPS's safe driving techniques and methods to teenage drivers. CDC will conduct an analysis of the UPS Road Code curriculum, provide recommendations and resources based on the most recent and best available science and provide in-depth consultation on and assistance with the evaluation of the UPS Road Code program.

  • Funding Partners: The UPS Foundation
  • Program Partners: CDC’s National Center for Injury Prevention and Control

> Evaluation of UPS’s Road Code Teen Driving Program

Gun Violence Prevention Advisory Committee Research Agenda

To develop a research agenda to address the causes and prevention of gun violence. To meet our goal, CDC is requesting the Institute of Medicine, through the National Academy of Sciences (NAS) and in collaboration with the National Research Council, to appoint an Advisory Committee to develop the proposed research agenda, using established NAS procedures. The proposed agenda will identify the most critical research questions that can be answered in the short-term (3-5 years) to improve our knowledge of the following: I) causes of gun violence; 2) interventions that prevent gun violence; and 3) strategies to minimize the public health burden of gun violence.

  • Funding Partners: Kaiser Permanente, The Joyce Foundation
  • Program Partners: CDC’s National Center for Injury Prevention and Control, National Academy of Sciences

> Gun Violence Prevention Advisory Committee Research Agenda

Heads Up Training for Healthcare Providers and Parents

To create a 45-minute interactive training course for healthcare professionals on concussion diagnosis and management, and to help CDC launch the Heads Up for Parents education campaign. The training for healthcare professionals and the education campaign for parents are part of CDC's larger Heads Up: Concussion in Youth Sports initiative that provides information on preventing, recognizing and responding to concussions to coaches, parents and athletes involved in youth sports.

 

  • Funding Partners: National Football League; National Operating Committee on Standards for Athletic Equipment
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Heads Up Training for Healthcare Providers and Parents

Innovative Uses of Technology in Existing Child Abuse Prevention Programs

To test whether technology, such as cell phones, Web-based learning and virtual reality software can be used to improve child abuse and maltreatment prevention programs.

  • Funding Partners: Doris Duke Charitable Foundation, The Annie E. Casey Foundation, Health Care Foundation of Greater Kansas City
  • Program Partners: Indiana University, University of Kansas, University of Notre Dame, University of Oklahoma Health Sciences Center, University of Washington, Wayne State University, CDC's National Center for Injury Prevention and Control

> Innovative Uses of Technology in Existing Child Abuse Prevention Programs

Intimate Partner Violence Prevention

To help CDC's Division of Violence Prevention award grants to state domestic violence coalitions to help them incorporate primary prevention strategies into their overall domestic violence programming

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Intimate Partner Violence Prevention

Optimizing Helmets to Reduce Work-Related Injuries

To optimize helmet design to reduce the severity of head injuries at construction worksites. The study will build on CDC’s research of digital human modeling of personal protective equipment and will respond to construction industry-wide needs for effective assessment methods to control exposures resulting in fatal and nonfatal work-related traumatic brain injury.

  • Funding Partners: Turner Construction Company, Liberty Mutual Insurance, Zurich American Insurance Company and ACE American Insurance Company
  • Program Partners: CDC’s National Institute for Occupational Safety and Health, West Virginia University’s Department of Neurosurgery and the International Safety Equipment Association

> Optimizing Helmets to Reduce Work-Related Injuries

Positive Parenting Program

To help CDC's Division of Violence Prevention launch the Positive Parenting Program (Triple P) model through partnerships between Federally Qualified Health Centers and local public health agencies.

  • Funding Partners: Doris Duke Charitable Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Positive Parenting Program

Public Health Leadership to Prevent Child Maltreatment

To build a state-based public health model for the prevention of child maltreatment by gathering and analyzing best practices and core components of approaches to prevent child maltreatment and disseminating best practices to help build a strong national prevention system that promotes safe, stable and nurturing relationships for children.

  • Funding Partners: Doris Duke Charitable Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Public Health Leadership to Prevent Child Maltreatment

Report on Youth Concussions in Sports

To conduct a portion of a study on sports-related concussions in youth, from elementary school through young adulthood, conducted by the Board on Children, Youth, and Families of the Institute of Medicine and the National Research Council. The resulting consensus report will drive improvements in the science base and allow for greater collaboration among researchers and practitioners working on sports concussion issues.

  • Funding Partners: National Football League Charities
  • Program Partners: CDC's National Center for Injury and Violence Prevention

> Report on Youth Concussions in Sports

Social Determinants of Health and Injury

To provide resources to translate academic literature on social and economic causes of inequities in health and safety into accessible formats for use by health practitioners, communities and the broader public; develop a conceptual framework and methods for collecting, analyzing and making use of data on the structures of decision making that generate health inequities in local jurisdictions; and produce a manual that can be used to guide the development and evaluation of interventions to address inequities in health and safety.

  • Funding Partners: W.K. Kellogg Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Social Determinants of Health and Injury

Together for Girls

To enable CDC to work with individual countries and regions to quantify the problem of sexual violence against girls and subsequently develop evidence-based policies and programs to protect children and prevent violence.

  • Funding Partners: Nduna Foundation, United Nations Population Fund
  • Program Partners: UNICEF, UNAIDS, UNIFEM, Grupo ABC, CDC's National Center for Injury Prevention and Control

> Together for Girls

Environmental Health

The places where people live, work and play can greatly impact their health. CDC conducts research that analyzes to what extent these possible environmental threats affect our health and who may be most at risk. The CDC Foundation helps CDC collaborate with universities and research institutions in the U.S. and around the world to investigate potential environmental health threats and make recommendations for how to mitigate their affects on our health.

Environmental Health Programs

Acrylamide Exposure and Breast Cancer

To explore the risk of breast cancer from exposure to acrylamide in a case control study of postmenopausal women with and without breast cancer.

  • Funding Partners: Danish Cancer Society
  • Program Partners: CDC's National Center for Environmental Health

> Acrylamide Exposure and Breast Cancer

Acrylamide Exposure and Risk of Endometrial and Ovarian Cancer

To assess exposure to acrylamide in a subset of the European Prospective Investigation into Cancer and Nutrition (EPIC) study cohort and assess possible associations between acrylamide exposure and endometrial and ovarian cancers.

  • Funding Partners: Bellvitge Biomedical Research Institute (IDIBELL)
  • Program Partners: CDC’s National Center for Environmental Health

> Acrylamide Exposure and Risk of Endometrial and Ovarian Cancer

Asthma and Secondhand Smoking

To quantify exposure to secondhand smoke by measuring levels of nicotine metabolites and then assess the relationship between secondhand smoke exposure and the development of asthma and allergy in children.

  • Funding Partners: Simon Fraser University
  • Program Partners: CDC's National Center for Environmental Health

> Asthma and Secondhand Smoking

Autism and Fetal Antibody Exposure

To test whether fetal exposure to sufficiently high levels of maternal antibodies could lead to the development of autism spectrum disorders.

  • Funding Partners: U.S. Army Medical Research and Materiel Command
  • Program Partners: CDC's National Center for Environmental Health

> Autism and Fetal Antibody Exposure

BPA Exposure and Risk for Obesity and Diabetes

To monitor the prospective association of bisphenol A (BPA) exposure with risk for obesity and diabetes. Additionally, the role of epigenetic factors in mediating the association between BPA exposure and risk for obesity and diabetes will be investigated. A pilot study will use preliminary data from 170 samples collected for the Emory Twins Study between 2002 and 2010.

  • Funding Partners: The University of Oklahoma Health Science Center
  • Program Partners: CDC’s National Center for Environmental Health

> BPA Exposure and Risk for Obesity and Diabetes

Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) Environmental Study

To examine the association of exposure to phthalates with health outcomes in child development using samples collected from participants of the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) study. CDC’s Organic Analytical Toxicology Branch will measure the urinary concentrations of phthalate metabolites in urine collected from CHAMACOS participants. Approximately 700 samples will be analyzed for phthalate metabolites.

  • Funding Partners: Children’s Environmental Health Laboratory, University of California Berkeley
  • Program Partners: CDC’s National Center for Environmental Health

> Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) Environmental Study

Childhood Autism from Genetics and the Environment

To compare the cognitive and adaptive functions of children with autism to normally developing and mentally retarded children and to evaluate the connection between high gestational folic acid levels and reduced risk for autism. CDC’s Division of Laboratory Sciences Nutritional Biomarkers Branch will measure 851 newborn dried blood spot samples from the State of California’s newborn screening bank in the “CHARGE” study, Childhood Autism Risks from Genetics and the Environment.

  • Funding Partners: National Institute of Environmental Health Sciences, Northwestern University Feinberg School of Medicine
  • Program Partners: CDC’s National Center for Environmental Health

> Childhood Autism from Genetics and the Environment

Concentrations of Polybrominated Diphenyl Ethers in Human Milk

To evaluate the lifestyle and demographic factors that contribute to the levels of polybrominated diphenyl ethers (PBDEs) in human milk.

  • Funding Partners: The Pennsylvania State University
  • Program Partners: CDC's National Center for Environmental Health

> Concentrations of Polybrominated Diphenyl Ethers in Human Milk

Dietary Intervention in Pregnancy

To examine whether a dietary intervention can reduce urinary concentrations of phthalate metabolites in pregnant women. This study will measure samples and investigate challenges to adopting changes in diet.

  • Funding Partners: University of Rochester, New York
  • Program Partners: CDC’s National Center for Environmental Health

> Dietary Intervention in Pregnancy

Early Childhood Exposure to PBDEs

To measure polybrominated diphenyl ethers (PBDEs) in cord blood plasma and in blood collected at three years in children in the Northern Manhattan cohort.  A detailed assessment of the home environment and cleaning habits, as well as a detailed dietary questionnaire that has been validated for this population to assess the potential contribution of dietary sources of PBDE to biomarker concentrations, will be conducted. There will be 46 human serum samples analyzed for persistent organic pollutants and serum lipids.

  • Funding Partners: Center for Environmental Research and Children's Health, UC Berkeley, School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Early Childhood Exposure to PBDEs

Environmental Exposure and ALS

To measure the levels of gamma-tocopherols, 25-hydroxyvitamine, pesticides and blood lead and study their association with the development of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease).

  • Funding Partners: Emory University
  • Program Partners: CDC's National Center for Environmental Health

> Environmental Exposure and ALS

Environmental Toxin Exposure in Mexican-American Children

To provide confirmation of previous laboratory results (by a lab other than CDC) for several organic chemicals from a minority population of children and adolescents residing in a highly agricultural region of Texas located in close proximity to two EPA-designated Superfund sites.

  • Funding Partners: The University of Texas MD Anderson Cancer Center
  • Program Partners: CDC's National Center for Environmental Health

> Environmental Toxin Exposure in Mexican-American Children

Exposure Assessment of Gulf Oil Spill

To measure volatile organic compounds (VOCs) and metal levels in approximately 100 blood samples from participants of the National Institute of Environmental Health Sciences’ Gulf long-term health study. Results from these samples will be used to characterize environmental exposures among adult clean-up workers residing in the four most affected Gulf States (Louisiana, Mississippi, Alabama and Florida) after completion of the oil spill clean-up.

  • Funding Partners: National Institute of Environmental Health Sciences and SRA International, Inc.
  • Program Partners: CDC’s National Center for Environmental Health

> Exposure Assessment of Gulf Oil Spill

Exposure of Toxins to Road Workers in Australia

To assist the New South Wales Environment Protection Authority in determining whether workers have been exposed to dioxins, furans, PCBs and/or organochlorine pesticides during road construction and to establish, if possible, the cause of ongoing health effects suffered by the workers on the construction site.

  • Funding Partners: New South Wales Environment Protection Authority
  • Program Partners: CDC’s National Center for Environmental Health

> Exposure of Toxins to Road Workers in Australia

Exposure to Polybrominated Diphenyl Ethers and Autism

To measure the levels of polybrominated diphenyl ethers, polychlorinated biphenyls and persistent pesticides in maternal serum and study the association with risk of autism.

  • Funding Partners: Kaiser Permanente
  • Program Partners: CDC's National Center for Environmental Health

> Exposure to Polybrominated Diphenyl Ethers and Autism

Folate Status in the U.K. Population

To determine folate status across the U.K. in order to establish a population baseline should mandatory folic acid fortification proceed.

  • Funding Partners: Human Nutrition Research at the Medical Research Council
  • Program Partners: CDC's National Center for Environmental Health

> Folate Status in the U.K. Population

Health Outcomes and Measures of the Environment

To analyze data through the Health Outcomes and Measures of the Environment (HOME) study, a prospective birth cohort of mothers and their children from Cincinnati, Ohio, who have been followed from the second trimester of pregnancy until the child is around 8 years old. 1,000 human serum and 74 milk samples will be analyzed for persistent organic pollutants (POPs) and serum lipids. Additionally, measurements of polyfluoroalkyl chemicals (PFCs) in approximate 800 serum samples will be taken. The data will be essential to showing the levels of serum of POPs and PFCs in the HOME cohort at age 1, 2, 3 and 5 years of age.

  • Funding Partners: University of Cincinnati College of Medicine; Simon Fraser University Research Accounting
  • Program Partners: CDC’s National Center for Environmental Health

> Health Outcomes and Measures of the Environment

Heavy Metal Exposure Near Copper Mines in Peru

To assess the potential exposure to heavy metals and metalloids in people living near an open pit copper mine in the Andes Mountains of Cusco, Peru. CDC plans to analyze urine samples from two communities of people living in the area. Previous environmental sampling has revealed heavy concentrations of elements in different samples of river sediments in communities near the mine.

  • Funding Partners: National Institute of Health of Peru (Instituto Nacional de Salud or INS)
  • Program Partners: CDC’s National Center for Environmental Health

> Heavy Metal Exposure Near Copper Mines in Peru

Impact of Flame Retardant Exposure on Children

To measure serum levels of polybrominated diphenyl ethers (PBDE), polychlorinated biphenyls (PCBs) and pesticides in 850 children at birth, at 2 to 3 and 5 to 7 years of age. This study will characterize the longitudinal impact of PBDE exposure, commonly known as flame retardant, occurring throughout childhood on neurodevelopment.

  • Funding Partners: Columbia University, New York
  • Program Partners: CDC’s National Center for Environmental Health

> Impact of Flame Retardant Exposure on Children

Incinerators Biomonitoring Study

To assess the relationship between modeled area level ambient dioxin exposure and individual level breast milk dioxin exposure in residents living near two municipal solid waste incinerators, Marchwood in Hampshire and Stockton-on-Tees in Cleveland, in England. A total of 100 human milk specimens will be analyzed for PCDDs/PCDFs/cPCBs. The study results will additionally help interpret the results of the national epidemiological study on municipal solid waste incinerators and birth outcomes being conducted by the Small Area Health Statistics Unit at Imperial College London.

  • Funding Partners: Imperial College London, St Mary's Campus
  • Program Partners: CDC’s National Center for Environmental Health

> Incinerators Biomonitoring Study

Maternal Organics Monitoring Study

To collect and analyze biological (blood, cord, urine) samples from 200 Alaska Native mother-infant pairs over the period of one year. The levels of persistent organic pollutants, heavy metals, cytokines, selenium and a fatty acid profile in pregnant women and newborn infants will be measured. Also measurements will be taken for levels of radioactive isotopes, phthalate, mercury, arsenic, polycyclic aromatic hydrocarbons and phytoestrogensin in the urine specimen of pregnant women. Associations of individual contaminants or groups of contaminants with pregnancy outcomes and risk of infectious disease as well as growth and development outcomes in the child’s first year of life will be investigated. Results will be provided to Alaska Native communities to help them create acceptable strategies to reduce exposure while maintaining their traditional diet as well as to better understand the health benefits of the traditional diet.

  • Funding Partners: Alaska Native Tribal Health Consortium
  • Program Partners: CDC’s National Center for Environmental Health

> Maternal Organics Monitoring Study

Measuring PAHs in a Cohort of NYC Women and Children

To evaluate whether exposure to PAHs during pregnancy adversely affects fetal development, asthma development and child health.

  • Funding Partners: Columbia University
  • Program Partners: CDC's National Center for Environmental Health

> Measuring PAHs in a Cohort of NYC Women and Children

Molecular Epidemiology of Multiple Xenoestrogen Exposure

To examine the relationship between xenoestrogen exposure (e.g., alkylphenols, bisphenol A, phthalates, and pyrethroid pesticides) and gene polymorphisms related to hormone receptors and breast cancer.

  • Funding Partners: Mount Sinai School of Medicine
  • Program Partners: CDC's National Center for Environmental Health

> Molecular Epidemiology of Multiple Xenoestrogen Exposure

Occupational Exposure to PCBs and Possible Health Effects

To assess occupational exposure to polychlorinated biphenyls (PCBs) and investigate the relationship between exposure and health effects.

  • Funding Partners: Middlesex-London Health Unit
  • Program Partners: CDC's National Center for Environmental Health

> Occupational Exposure to PCBs and Possible Health Effects

Ohio River Valley PFOAs and Related Health Risks

To  conduct a retrospective exposure assessment study of 250 persons who lived in the Ohio River Valley during the 1990s, to determine if geographically defined populations along the River have serum concentrations of perfluoroalkyl compounds (PFCs), notably perfluorooctanoate (PFOA), that are greater than age-specific population distributions established using data from NHANES 2003-2004, and the existence of a pattern in the geographical distribution of those with elevated concentrations, influenced by the type of water treatment system.

  • Funding Partners: University of Cincinnati
  • Program Partners: CDC’s National Center for Environmental Health

> Ohio River Valley PFOAs and Related Health Risks

PCBs, Phthalates and Male Reproductive Health

To determine if and how exposure to PCBs and phthalates affects male fertility.

  • Funding Partners: Harvard University, School of Public Health
  • Program Partners: CDC's National Center for Environmental Health

> PCBs, Phthalates and Male Reproductive Health

Perchlorate and Thyroid Hormones Levels in Pregnant Women and Infants

To investigate the associations between perchlorate and thyroid hormone levels in pregnant women and infants using maternal blood, urine samples, fetal cord blood and questionnaires from samples collected by the California Department of Public Health in San Diego County. The sample collection took place from 1999-2001 from a large cohort of pregnant women. Approximately 2,127 urine samples will be analyzed for perchlorate, nitrate, thiocyanate, iodide and creatinine.

  • Funding Partners: The School of Public Health at the University of California, Berkeley
  • Program Partners: CDC’s National Center for Environmental Health

> Perchlorate and Thyroid Hormones Levels in Pregnant Women and Infants

Phthalate Exposure in Pregnant Women Living in New York

To measure levels of phthalate metabolites in urine samples of pregnant women in New York  City. 

  • Funding Partners: Columbia University
  • Program Partners: CDC's National Center for Environmental Health

> Phthalate Exposure in Pregnant Women Living in New York

Phthalates in Pediatric Asthma Patients

To assess the level of exposure to phthalates in children with asthma from inhalers and spacers used to deliver corticosteroids.

  • Funding Partners: Icahn School of Medicine at Mount Sinai
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalates in Pediatric Asthma Patients

Predictors of Mammary Gland Development

To assess the relation between putative early markers of breast cancer risk and exposure to endocrine-disrupting chemicals (EDCs), specifically phenols such as bisphenol A (BPA) and phthalates in urinary concentrations of select phenols and phthalate metabolites in a cohort of Chilean girls.

  • Funding Partners: Brigham and Women’s Hospital, A Teaching Affiliate of Harvard Medical School
  • Program Partners: CDC’s National Center for Environmental Health

> Predictors of Mammary Gland Development

Pregnancy and Phthalates Exposure

To measure the levels of phthalates and association with potential birth outcomes in a population of pregnant women living in Puerto Rico.

  • Funding Partners: University of Michigan School of Public Health
  • Program Partners: CDC's National Center for Environmental Health

> Pregnancy and Phthalates Exposure

Prenatal Exposure to Persistent Organic Pollutants

To measure persistent organic pollutants (POPs) and heavy metal concentrations in women in the third trimester of their pregnancy as proxy indicators of fetus exposure in the same period of time. An association between these concentrations and the neurodevelopment and anogenital distance in the fetus will also be studied. Associations will be controlled among other variables by maternal lead, mercury and arsenic levels. A total of 34 human serum pools will be analyzed for persistent organic pollutants and lipids.

  • Funding Partners: National Institute of Public Health of Mexico
  • Program Partners: CDC’s National Center for Environmental Health

> Prenatal Exposure to Persistent Organic Pollutants

Prenatal Exposure to PFCs and Child Growth and Development

To investigate the association of prenatal polyfluoroalkyl chemicals (PFC) exposure with growth and neurodevelopment in children. The study will also examine the associations of prenatal PFC plasma concentrations with measures of somatic growth and metabolic outcomes from birth to 7 years of age, the association between prenatal PFC plasma concentrations and neurodevelopment from age 6 months to 7 years and the association between maternal PFC plasma concentrations during the first trimester of pregnancy and newborn thyroid hormone whole blood levels, as one potential mediator to effects on growth and neurodevelopment.

  • Funding Partners: Boston University School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Prenatal Exposure to PFCs and Child Growth and Development

Responsive Changes in Levels of PAH Biomarkers

To monitor the responsive changes in levels of polycyclic aromatic hydrocarbon (PAH) biomarkers in humans when they are subjected to movement from a low PAH-polluted area (Brisbane, Australia) to a high PAH-polluted area (Hanoi, Vietnam) and vice versa. Background levels of PAH biomarkers in urine collected from participating families, children in Hanoi (highly polluted) and Brisbane (relatively clean metropolitan city), will be monitored and compared with the level of PAH biomarkers in a subgroup that is moving between the two cities.

  • Funding Partners: University of Queensland, Australia
  • Program Partners: CDC’s National Center for Environmental Health

> Responsive Changes in Levels of PAH Biomarkers

The Green Housing Study

In partnership with the U.S. Department of Housing and Urban Development, CDC will collect survey and biomarker data from residents and take environmental measurements in homes. Specifically, CDC’s Organic Analytical Toxicology Branch will measure environmental phenols and phthalate metabolites in approximately 144 urine samples collected from residents of green and traditional housing. The economic impact of the “greening” of housing, particularly related to health, will be assessed.

  • Funding Partners: Silent Spring Institute
  • Program Partners: CDC’s National Center for Environmental Health

> The Green Housing Study

Toxicants and Infant Male Reproductive Systems

To assess the effects of prenatal phthalate exposure on the developing male reproductive system. Anogenital distance will be used as a marker of exposure to reproductive toxicants and their effects. CDC’s Organic Analytical Toxicology Branch will provide biomonitoring data on phthalate metabolites in 786 urine samples collected prenatally from mothers who participated in the Infant Development and the Environment (TIDES) Study.

  • Funding Partners: Icahn School of Medicine at Mount Sinai
  • Program Partners: CDC’s National Center for Environmental Health

> Toxicants and Infant Male Reproductive Systems

Urinary Sodium Calibration Study in Adults

To analyze urine sodium, potassium, chloride and creatinine in 5 different types of urine samples from ~500 participants aged 45-79 years old. The major objectives of the calibration study are to assess how well the sodium excretion estimated from a timed urine correlates with data from a 24-hour urine collection, to assess the correlation of 24-hour sodium excretion with different timed urines collected at varying times of day, as well as to develop calibration equations to estimate 24-hour urine sodium excretion using data from timed urine samples.

  • Funding Partners: Northwestern University Feinberg School of Medicine
  • Program Partners: CDC’s National Center for Environmental Health

> Urinary Sodium Calibration Study in Adults

Vitamin D and Multiple Sclerosis in Australia

To analyze serum vitamin D in up to 100 participants who were recruited into a previous baseline study as a result of having an episode of central nervous system demyelination, which is often a precursor to multiple sclerosis.

  • Funding Partners: National Centre for Epidemiology and Population Health at Australian National University
  • Program Partners: CDC’s National Center for Environmental Health

> Vitamin D and Multiple Sclerosis in Australia

Emergency Preparedness & Response

CDC is a key player in preparing the nation for large-scale public health emergencies — whether terrorist attacks, pandemic flu or natural disasters. CDC works with its partners at the national and local levels to develop and improve emergency preparedness plans that can be activated the moment disaster strikes. In addition, CDC experts are often among the first on the frontlines of a disaster, monitoring for potential disease outbreaks and assessing damage to healthcare infrastructures. The CDC Foundation has a number of funds and programs designed to support CDC's emergency preparedness and response activities.

Emergency Preparedness & Response Programs

Emergency Response Fund

The Emergency Response Fund helps CDC respond to public health emergencies and, when needed, allows CDC experts on the frontlines of an emergency to immediately purchase the specialized equipment or services needed to get the job done.

  • Funding Partners: IBM; Kaiser Permanente; Preparis Inc.; Robert Wood Johnson Foundation; T-Mobile USA, Inc.; multiple organizations and individuals
  • Program Partners: CDC's Office of Public Health Preparedness and Response

> Emergency Response Fund

Global Disaster Response Fund

To provide immediate, flexible resources to CDC experts, when their help is requested by health officials in another country to address a public health emergency - whether a natural disaster like the tsunami in Southeast Asia or the earthquake in Haiti or an emerging disease outbreak like SARS or H1N1.

  • Funding Partners: Caring for Colorado; The Dayton Foundation; Charles F. Dillon Revocable Trust; GE Foundation; Hewlett Packard; Kaiser Permanente; Nelson Family Foundation; The Robert Wood Johnson Foundation; The UPS Foundation; multiple organizations and individuals
  • Program Partners: CDC's Office of Public Health Preparedness and Response; CDC's Center for Global Health

> Global Disaster Response Fund

Meta-Leadership Summit for Preparedness

The Meta-Leadership Summit for Preparedness is a unique national initiative to better prepare business, government and nonprofit leaders to work effectively together during a public health or safety crisis. Through the Summit, leaders learn skills needed for effective action during times of crisis and build organizational connections to strengthen community preparedness for responding to and recovering from emergencies.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: National Preparedness Leadership Initiative - Harvard School of Public Health, CDC's Office of Public Health Preparedness and Response

> Meta-Leadership Summit for Preparedness

Whole Community Approach to Emergency Management

To help develop and implement FEMA's Whole Community Approach to Emergency Management, an effort to promote community engagement strategies that position local residents in leadership roles in planning, organizing and sharing accountability for the success of local disaster management efforts.

  • Funding Partners: Federal Emergency Management Agency
  • Program Partners: CDC's Office of Public Health Preparedness and Response

> Whole Community Approach to Emergency Management

Occupational Health & Safety

CDC's National Institute for Occupational Safety and Health (NIOSH) is the federal agency responsible for conducting research and making recommendations for the prevention of work-related injury and illness. NIOSH gathers information, conducts scientific research, and translates the knowledge gained into products and services, including scientific information products, training videos and recommendations for improving safety and health in the workplace.The CDC Foundation helps NIOSH collaborate with industry leaders, employers and research institutions to advance learning and effectively address occupational health threats.

Occupational Health & Safety Programs

Evaluating Workplace Safety Practices

To evaluate a new workplace safety program at a helicopter manufacturing facility to reduce work-related musculoskeletal and traumatic injuries.

  • Funding Partners: Sikorsky Aircraft Corporation
  • Program Partners: CDC's National Institute for Occupational Safety and Health

> Evaluating Workplace Safety Practices

Pesticides and Parkinson's Disease

To investigate the potential relationship between occupational exposure to pesticides and the development of Parkinson’s disease.   

  • Funding Partners: Pacific Health Research Institute
  • Program Partners: CDC's National Institute for Occupational Safety and Health, Honolulu Heart Program/Honolulu-Asia Aging Study, Research Triangle Institute, National Institute of Neurological Disorders and Stroke

> Pesticides and Parkinson's Disease

Reproductive Health Issues and Exposure to PBBs

To measure polybrominated biphenyls (PBBs) and determine the extent of endocrine disruption resulting from exposure to these compounds.

  • Funding Partners: Emory University
  • Program Partners: CDC's National Institute for Occupational Safety and Health

> Reproductive Health Issues and Exposure to PBBs

Time to Conceive and Biomarkers of Infertility

To assess the reproductive potential of women exposed to occupational hazards.

  • Funding Partners: University of North Carolina at Chapel Hill
  • Program Partners: CDC's National Institute for Occupational Safety and Health

> Time to Conceive and Biomarkers of Infertility

Public Health Leadership

The CDC Foundation recognizes individuals who make significant contributions to improving health and supports learning experiences to inspire future generations of public health leaders. Many of the awards are made possible by contributions from individuals and organizations to a CDC Foundation endowment or restricted fund.

 

Public Health Leadership Programs

CDC Foundation Hero Award

The CDC Foundation Hero Award recognizes an individual who has made a significant contribution to improving the public’s health through exemplary work in advancing CDC’s mission of promoting health and quality of life by preventing and controlling disease, injury and disability.

  • Funding Partners: CDC Foundation
  • Program Partners: CDC Foundation

> CDC Foundation Hero Award

CDC-Hubert Global Health Fellowship

To provide an opportunity for third- and fourth-year medical and veterinary students to gain public health experience in an international setting. Hubert fellows spend six to twelve weeks in a developing country working on a priority health problem in conjunction with CDC staff.

  • Funding Partners: O.C. Hubert Charitable Trust, Pfizer
  • Program Partners: CDC's Office of Surveillance, Epidemiology and Laboratory Services

> CDC-Hubert Global Health Fellowship

David J. Sencer CDC Museum

The David J. Sencer CDC Museum serves as CDC’s gateway to the public, and is dedicated to comprehensive scientific learning and outreach. Composed of innovative permanent exhibits representing the breadth of CDC’s work and history, topical changing exhibits, a theater and a classroom, this facility serves to educate all who visit about public health and the important work of CDC, with a special emphasis on curriculum-based educational workshops and camps targeting middle- and high-school students.

  • Funding Partners: Association of State and Territorial Health Officials; The Florence C. and Harry L. English Memorial Fund; The Harriet McDaniel Marshall Trust; The John and Mary Franklin Foundation; The Morris Family Foundation, Inc.; The Walter H. and Marjory M. Rich Memorial Fund; The Thomas Guy Woolford Charitable Trust Fund
  • Program Partners: CDC's Office of Associate Director for Communication

> David J. Sencer CDC Museum

David J. Sencer EIS Alumni Association Scholarship Fund

To provide travel scholarships to potential EIS applicants to attend the EIS Conference.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: EIS Alumni Association

> David J. Sencer EIS Alumni Association Scholarship Fund

Donald C. Mackel Award

To recognize the best collaborative work between epidemiology and laboratory scientists presented at the annual EIS Conference.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: EIS Alumni Association

> Donald C. Mackel Award

Iain R.B. Hardy, M.D., EIS '92 Memorial Award

To honor an EIS officer or recent graduate (within five years) for contributions to vaccine-preventable diseases.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: Epidemic Intelligence Service

> Iain R.B. Hardy, M.D., EIS '92 Memorial Award

James Buffington Jr. and Lois Chapman Buffington Endowment for the Alexander D. Langmuir Prize

To honor a current or former EIS Officer (within one year of graduation) for the best scientific manuscript submitted to the EISAA Executive Committee for review.

  • Funding Partners: Established by Joanna Buffington, M.D., EIS '90 and supported by multiple individuals
  • Program Partners: EIS Alumni Association

> James Buffington Jr. and Lois Chapman Buffington Endowment for the Alexander D. Langmuir Prize

James H. Steele, D.V.M., EIS '75 Veterinary Public Health Award

To recognize current or former EIS Officers (within five years of having completed EIS training) who have made outstanding contributions in the field of veterinary public health.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: EIS Alumni Association

> James H. Steele, D.V.M., EIS '75 Veterinary Public Health Award

Linda Saltzman New Investigator Award

The Linda Saltzman New Investigator Award recognizes an outstanding new investigator with 2-10 years of experience working in the field of domestic violence, violence against women or dating violence. Futures Without Violence, CDC and a committee of experts selects an outstanding individual to receive the award every other year beginning 2012. The recipient receives passage to the National Conference on Health and Domestic Violence.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Linda Saltzman New Investigator Award

Marge and Bill Watson Endowment for the William C. Watson Jr. Medal of Excellence

The CDC Medal of Excellence was established in 1977 as the premiere service award for CDC employees and was renamed for William Watson in 1985 on the occasion of his retirement from CDC. In 1999, Marge and William Watson established the Watson Endowment, which provides permanent funding for a cash award to be given by the Foundation to recipients of the Watson Medal of Excellence each year.

  • Funding Partners: Established by Marge and Bill Watson and supported by multiple individuals
  • Program Partners: CDC

> Marge and Bill Watson Endowment for the William C. Watson Jr. Medal of Excellence

Pappaioanou Veterinary Public Health and Applied Epidemiology Fellowship

This fellowship will provide competitively selected veterinarians and 3rd and 4th year veterinary medical students with opportunities in an applied hands-on training experience in epidemiology, public health or global health. Each fellow will spend up to one full year at CDC working on a U.S.-focused or global public health project. 

  • Funding Partners: Marguerite Pappaioanou, D.V.M., M.P.V.M., Ph.D., D.A.C.V.P.M.
  • Program Partners: Centers for Disease Control and Prevention

> Pappaioanou Veterinary Public Health and Applied Epidemiology Fellowship

Paul C. Schnitker, M.D., EIS '69 Endowed Memorial Award for Global Public Health

To recognize a current EIS Officer at CDC or a first-year EIS alumnus/a who has made an unusual contribution to global public health.

  • Funding Partners: multiple individuals and organizations
  • Program Partners: Epidemic Intelligence Service

> Paul C. Schnitker, M.D., EIS '69 Endowed Memorial Award for Global Public Health

Thomas A. Bartenfeld III Award for Public Health Practice

On an annual basis, the Thomas A. Bartenfeld III Award for Public Health Practice will recognize an individual who reflects excellence in public health practice – that rare combination of perspective grounded in frontline, day-to-day public health work and constant drive toward meaningful program measurement and outcomes.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC

> Thomas A. Bartenfeld III Award for Public Health Practice